Perspective TherapeuticsCATX
13F holders, Q2 2024 (June 30)2holders −102
0new positions
102sold out
$7.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, down 102 from Q1 2024. 0 opened new positions and 102 sold out. The largest holders were Portland Investment Counsel Inc. ($698K) and JDM Financial Group LLC ($37K).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 102 | $295.8M |
All 13F filers, Q1 2024 → Q2 2024: 247,454,848 shares sold, net −247,454,848 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Portland Investment Counsel Inc. | 0.25% | Reduce -79.6% | 70,001 | $698K |
| JDM Financial Group LLC | 0.03% | No change | 35,000 | $37K |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.